{"database": "lobbying", "table": "lobbying_activities", "rows": [[1733025, "ef8ec07d-9ce6-47d9-9332-e21ba6d76f4b", "Q3", "NELSON MULLINS RILEY & SCARBOROUGH", 285871, "INDIVIOR (FORMERLY, RECKITT BENCKISER PHARMACEUTICALS, INC.)", 2015, "third_quarter", "PHA", "Any legislation and regulation to the treatment of opioid abuse.", "HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2015-10-16T09:08:18.190000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1733025"], "units": {}, "query_ms": 0.308866030536592, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}